Aidoc vs Qure.ai

A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.

Aidoc Always-on clinical AI that triages CT findings — ICH, PE, spinal fract... Visit Qure.ai FDA-cleared AI radiology platform detecting TB, stroke, lung cancer an... Visit
RECATOOLS Score 8.2 / 10 8.2 / 10
Capability 9.2 9
Value for money 6.5 7.5
Ease of use 7.5 7
ASEAN readiness 5.5 8.5
API quality 7 7
Pricing Enterprise Enterprise
Free tier No free tier; demo available on request No free tier; enterprise contracts only; trial demos available via sales
Paid from Custom enterprise pricing; contact sales for per-site or per-volume quotes Custom enterprise pricing; contact sales for per-scan or site-licence quotes
Has API
Open source
Free to use
Users nearly 2,000 hospitals worldwide; 150+ US health systems; 60M+ cases/year 34M+ lives impacted across 4,800+ clinical sites in 105+ countries (as of late 2025)
Founded 2016 2016
Maker Aidoc Medical Ltd. Independent (Series D — Lightspeed, 360 ONE Asset, Merck GHI Fund)
Verdict

Aidoc leads the FDA-cleared radiology AI market by clearance count and clinical breadth. Its CARE foundation model — the first to receive FDA clearance for 14 simultaneous abdominal CT indications — represents a genuine...

Qure.ai is one of the most credentialled and widely deployed AI radiology platforms in the world, with a regulatory portfolio (26 FDA-cleared indications, Class IIb CE under EU MDR, CDSCO Class B in India, registrations...

Full review → Full review →
← Back to AI Directory

Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.